Sma clinical data, outcome measures and registries

Spinal muscular atrophy (SMA) is a hereditary neuromuscular disease marked by the progressive weakness and muscle loss, with obesity as well as malnutrition, gastrointestinal dysmotility, and osteoporosis. Many patients exhibit metabolic abnormalities, such as insulin resistance, diabetes and fatty acid oxidation disorder. This observational study consisted of a nutritional and medical history survey of children with SMA type II and III collected between 2008-2015. We evaluated 109 patients, 55% of them were males, which 78% SMAII and 22% SMAIII.
Source: Neuromuscular Disorders - Category: Neurology Authors: Source Type: research